Biomatrica

Biomatrica
Private
Industry Biotechnology
Founded 2004 (2004)
Headquarters San Diego, CA, United States
Area served
 Worldwide
Website www.biomatrica.com

Biomatrica is a United States-based biotechnology company that develops biological stabilizers for the purpose of expanding the availability and accuracy of medical diagnostics. Specifically, the company focuses on improving the stability of biological materials, such as DNA, RNA, proteins, and cells, across the diagnostic workflow, from patient samples to diagnostic test reagents. Biomatrica scientists have developed alternatives to existing preservation technologies, such as cold storage and lyophilization (freeze-drying), to prevent degradation of perishable biological materials. Biomatrica's technologies are used in applications such as pre-analytic sample collection, diagnostic assays, biobanking, forensics, and basic research.

History

Biomatrica was founded by scientists, Judy Müller-Cohn, PhD, and Rolf Müller, PhD, in 2004. Prior to founding Biomatrica, both had worked many years in San Diego’s biotechnology industry. Judy Müller-Cohn was previously Director of Business Development at Digital Gene Technologies and a scientist at Mycogen/ Dow Agrosciences. Rolf Muller had been a visiting Scientist and Director of Assay Development and High Throughput Screening for the HIV Core Program Project Grant at San Diego’s prestigious Scripps Research Institute. Prior to that, he served as a scientific director at HK Pharmaceuticals and Digital Gene Technologies, as well as a scientist at the Salk Institute studying cell signaling and viral based gene therapy approaches.[1][2]

Biomatrica initially developed ambient temperature storage reagents for DNA and RNA. The company’s core technology was inspired by the phenomenon of anhydrobiosis, the ability of some organisms to hibernate in a desiccated state during dry periods, and then reanimate upon contact with water.[1] Focusing their studies on microscopic, desert-dwelling creatures called Tardigrades, which undergo anhydrobiosis for up to 120 years, Biomatrica scientists identified how to chemically mimic the mechanism of anhydrobiosis. According to Rolf Müller, “What we create(d) is a thermostable, dissolvable glass that packages every single molecule in a sample.” [3] Following stabilization at room temperature with Biomatrica's chemical reagents, biological specimens could be rehydrated for subsequent studies with the addition of a few drops of water.

Since 2012, the company has become increasingly focused on its pre-analytic collection and assay stabilization service businesses, described below.

Products and Services

The company's first product was a dry, synthetic polymer, "DNAstable" (originally “SampleMatrix”), a chemical formulation that stabilized purified DNA at ambient temperature. In 2006, it was awarded the Most Innovative Product of the Year award from the San Diego non-profit technology/business organization CONNECT.[4]

The following year, the company released RNAstable and CloneStable, dry chemical reagents optimized for stabilizing purified RNA and bacterial plasmid DNA, respectively.[5]

In 2007, the German biotechnology company, Qiagen, licensed DNAstable for sale under the trade name QIAsafe. Biomatrica and Qiagen subsequently co-developed QIAsafe Blood, an ambient temperature stabilization reagent for unpurified DNA in whole blood.[6][7]

Also in 2007, Biomatrica released a line of molecular and forensic assay enhancement products. The first, PCRboost, was developed for enhancement of PCR performed on degraded and trace DNA samples.[5] The second, STRboost, allowed improved results in forensic DNA analysis of degraded and low quantity genetic evidence using multiplex STR testing.

Biomatrica began commercialization of preanalytical products in 2009 with the launch of its “gard” product line. These products include RNAgard Blood, DNAgard Blood, and DNAgard Tissue and Cells, products designed to stabilize biological samples from collection to analytical testing.[5] In 2013, the company launched a device, DNAgard Saliva, for the collection of salivary DNA samples to be used in a variety of research studies. In 2015, a completely redesigned and improved version of this device was launched under the name DNAgard Saliva HT. This new version is designed and optimized for use by high-throughput laboratory automation instruments.

Liquid versions of DNAstable and RNAstable were launched as DNAstable LD and RNAstable LD in 2011 and 2012, respectively. These liquid products provide more flexibility for diverse experimental formats, including those utilizing automated instrumentation.[5]

In 2012, the company began offering custom stabilization services to diagnostic assay manufacturers under the trade name, AssayStable. This service allowed improved manufacturing and stability of diagnostic test kits. After completing several successful contracts with large diagnostic manufacturers, the company launched a related service, PCRstable, that focused specifically on improving stability of PCR-based, molecular diagnostic assays, including those using microfluidic chips and specialized cartridges and cassettes.[8]

Partnerships and Agreements

Licensing agreements for Biomatrica technologies were signed with the large German biotechnology company, Qiagen, in 2007 and 2009.[7]

Following the launch of DNAstable, the company gained the interest of major law enforcement organizations, such as the California Department of Justice, which sought to benefit from the new product through inexpensively stabilizing DNA samples from crime scenes for forensics purposes. Other major law enforcement organizations, including sheriffs’ departments in Orange County, CA Los Angeles, CA, and Palm Beach, FL, have adopted ambient temperature forensic sample management systems based on Biomatrica’s technologies.[1]

HMO giant, Kaiser Permanente adopted DNAstable for a large biobanking project in 2010.[9]

Also in 2010, Biomatrica signed a collaborative research and development agreement (CRADA) with United States Army Medical Research Institute for Infectious Diseases (USAMRIID) to develop and test new technologies for ambient temperature stabilization of clinical and biological samples.[10]

The same year, Biomatrica began a partnership agreement with the U.S. National Cancer Institute (NCI) for biomarker stabilization and SAIC-Frederick to improve molecular analysis of tumors.[11]

In 2011, the company announced a strategic partnership agreement with In-Q-Tel, an independent, strategic investment firm that identifies technologies to support the mission of the U.S. intelligence community.[12]

Other prominent government agencies testing Biomatrica’s technology included NASA and the U.S. Navy.[13]

In 2013, Biomatrica's DNAstable was featured in video created by Harvard University’s Sabeti Laboratory on collecting and transporting biological samples from Lassa Fever survivors from Africa to USA.[14]

In 2014, Biomatrica and American Type Tissue Culture (ATCC) signed a licensing agreement for Biomatrica to supply its DNA & RNA stabilization reagents to ATCC for use in the latter company’s DNA and RNA standards.[15]

Also in 2014, Biomatrica and the prominent chemical and biochemical supply company, Sigma-Aldrich, signed an agreement for the worldwide distribution of Biomatrica’s stabilization reagents.[16]

Corporate governance

References

  1. 1 2 3 Steve Chapple (December 4, 2011). "Nothing frozen in Biomatrica’s storage process". San Diego Union-Tribune. Retrieved 7 August 2012.
  2. ↑ Elizabeth Malloy (September 22, 2006). "Room Temperature Storage Key to New Biotech’s Ambition". San Diego Daily Transcript. Retrieved 19 August 2012.
  3. ↑ Blow, Nathan (2009). "Biobanking: freezer burn". Nature Methods 6 (2): 173–178. doi:10.1038/nmeth0209-173. Retrieved 8 August 2012.
  4. ↑ "James Flanigan (September 17, 2008). "Helping New Technologies Grow Into Businesses, the San Diego Way". The New York Times. Retrieved 08 August 2012.
  5. 1 2 3 4 "Biomatrica Corporate Facts Sheet", Retrieved 08 March 2015
  6. ↑ "Biomatrica and Qiagen Enter Into Marketing Agreement for Shipment and Storage Products" Genetic Engineering News June 7, 2007. Retrieved August 20, 2012.
  7. 1 2 "QIAGEN’s New Product Line, QIAsafe DNA Blood, has been co-developed with Biomatrica and is based on Biomatrica’s SampleMatrix Technology", Qiagen Press Release, Retrieved 08 August 2012.
  8. ↑ "Biostabilization Advances Enable Next-Gen Dx" Genetic Engineering News October 13, 2014. Retrieved April 8, 2015.
  9. ↑ Palmer, Roxanne (2010). "Companies hope to bring DNA storage in from the cold". Nature Medicine 16 (10): 1056–1057. doi:10.1038/nm1010-1056b. PMID 20930728. Retrieved 20 August 2012.
  10. ↑ "Biomatrica and USAMRIID Sign CRADA to Develop Biological Sample Stabilization Reagents" Genetic Engineering & Biotechnology News, July 28, 2011. Retrieved 08 August 2012.
  11. ↑ "SAIC-Frederick and Biomatrica Collaborate to Improve Molecular Analysis in Cancer Research" SAIC News, May 31, 2011. Retrieved 08 August 2012
  12. ↑ "Biomatrica Secures Strategic Partnership Agreement with In-Q-Tel" Homeland Security News, February 23rd, 2011. Retrieved 08 August 2012
  13. ↑ "Biomatrica Goes After $34B Market for Preserving Lab Samples"San Diego Business Journal January 22, 2007. Retrieved 08 August 2012.
  14. ↑ Gire, Stephen. "DIY SCIENCE: Hunting for valuable data in rural Africa". http://youtube.com. Ridhi Tariyal and Stephen Gire. Retrieved 9 March 2015. External link in |website= (help)
  15. ↑ staff reporter, GenomeWeb. "Biomatrica, ATCC Sign Licensing Deal". http://genomeweb.com. GenomeWeb LLC. Retrieved 9 March 2015. External link in |website= (help)
  16. ↑ staff reporter, GenomeWeb. "Sigma-Aldrich to Distribute Biomatrica's Biospecimen Storage Products". http://genomeweb.com. GenomeWeb LLC. Retrieved 9 March 2015. External link in |website= (help)

External links

This article is issued from Wikipedia - version of the Thursday, August 06, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.